Effects of anti-platelet drugs on circulating endotheial progenitor cells and oxidative stress in diabetic patients with ischemic cerebrovascular diseases
Phase 4
- Conditions
- diabetic patients with ischemic cerevrobascular diseases
- Registration Number
- JPRN-UMIN000000537
- Lead Sponsor
- Osaka City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients who is treated with cilostazol 2) patients who suffers from bleeding disorders 3) patients with unstable congestive heart failure or angina pectoris 4) patients with allergy against cilostazol 5) pqtients with allergy against aspirin 6) patients with cardiac diseases associated with cereberal embolism 7) patients with malignant diseases or hard to be followed 8) patients who are judged to be inappropriate for inclusion
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method circulating endothelial progenitor cells, markers of oxidative stress
- Secondary Outcome Measures
Name Time Method cerevrovascular events, the extent of lacuna stroke